Literature DB >> 16307346

An atypical case of POEMS syndrome with IgG kappa M protein and end stage renal failure.

Belda Dursun1, Mehmet Artac, Halil Ibrahim Varan, Bahar Kilicarslan Akkaya, Gulten Karpuzoglu, Gultekin Suleymanlar.   

Abstract

POEMS syndrome is a rare plasma cell dyscrasia which is characterized by small amounts of monoclonal protein, and a multisystem complex manifested by various combinations of polyneuropathy, organomegaly, endocrinopathy and skin changes. Here, we presented an atypical case of POEMS syndrome with IgG kappa monoclonal protein, chronic demyelinating polyneuropathy, hepatosplenomegaly, hypothyroidism, gynecomastia and severe renal impairment. The finding of IgG kappa type of monoclonal protein in our patient was interesting because the majority of cases were reported to have lambda light chain. Also, the absence of typical skin and bone lesions were atypical. Though speculative, these atypical features may account for the unusual presentation of this case. Our patient rapidly progressed to end-stage renal failure and died of cachexia. Renal involvement in POEMS syndrome is rare but may show substantial clinical and pathological variations. Proteinuria, hematuria, renal dysfunction and renal failure requiring hemodialysis can be seen. The pathogenesis of renal dysfunction is unclear. As a conclusion, POEMS syndrome may present with diverse clinicopathologic manifestations. In this syndrome, renal involvement may lead to end stage renal failure and the course may be fatal due to severe polyneuropathy and wasting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307346     DOI: 10.1007/s11255-004-0008-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

1.  Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease.

Authors:  L Bélec; A S Mohamed; F J Authier; M C Hallouin; A M Soe; S Cotigny; P Gaulard; R K Gherardi
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

2.  Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor.

Authors:  M Soubrier; J J Dubost; A F Serre; J M Ristori; B Sauvezie; P Cathebras; J C Piette; A Chapman; F J Authier; R K Gherardi
Journal:  Arthritis Rheum       Date:  1997-04

3.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

4.  A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome.

Authors:  Y Nakamoto; H Imai; T Yasuda; H Wakui; A B Miura
Journal:  Nephrol Dial Transplant       Date:  1999-10       Impact factor: 5.992

5.  Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.

Authors:  M Soubrier; C Sauron; B Souweine; C Larroche; B Wechsler; L Guillevin; J C Piette; H Rousset; P Deteix
Journal:  Am J Kidney Dis       Date:  1999-10       Impact factor: 8.860

6.  Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.

Authors:  G D Miralles; J R O'Fallon; N J Talley
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

7.  Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.

Authors:  P A Bardwick; N J Zvaifler; G N Gill; D Newman; G D Greenway; D L Resnick
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

8.  POEMS syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy, and renal enlargement.

Authors:  A G Fam; J D Rubenstein; D H Cowan
Journal:  Arthritis Rheum       Date:  1986-02

9.  Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases.

Authors:  K Takatsuki; I Sanada
Journal:  Jpn J Clin Oncol       Date:  1983-09       Impact factor: 3.019

10.  Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome.

Authors:  R K Gherardi; L Bélec; M Soubrier; D Malapert; M Zuber; J P Viard; L Intrator; J D Degos; F J Authier
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

View more
  1 in total

1.  Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.

Authors:  Sho Ikeda; Takahiro Kobayashi; Masaya Saito; Atsushi Komatsuda; Kumi Ubukawa; Yoshihiro Kameoka; Naoto Takahashi
Journal:  Intern Med       Date:  2019-08-06       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.